APTO Earnings

APTO reported its FY2024Q1 earnings on 2024-05-14, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was -0.73, surpassing the expected -0.82 by 10.98%. The stock experienced a 4.24% price change on the earnings day and a -2.54% change over the next five days, reflecting market reactions to the results.

Following APTO's FY2024Q1 earnings announcement on 2024-05-14, the stock price moved by 4.24% on the day of the release. Over the subsequent five days, it saw a -2.54% change. Historically, APTO's stock price tends to shift by an average of -4.06% in the 10 days leading up to earnings and 0.03% in the 10 days following, providing insight into potential market.

For , analysts estimate APTO's annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between APTO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, APTO's stock price typically moves by -4.06% in the 10 days before its earnings and 0.03% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The company's financial health is concerning, with a limited cash runway only through March 2024, increasing net loss, and high R&D expenses. While there are potential growth opportunities in expanding trials and partnerships, the lack of secured funding and competitive market challenges overshadow these positives. The Q&A did not reveal significant positive insights to alter this outlook. Overall, the financial strain and uncertainty about funding and regulatory approval suggest a negative sentiment, likely leading to a stock price decline of -2% to -8%.